Related Topics News -

     
 Detail   |   Print 
     
《業績》和鉑醫藥全年純利9,133萬美元增32倍 不派息
2026-03-31T  
和鉑醫藥HBM7575治療特應性皮炎新藥臨床獲批
2026-03-09T  
和鉑醫藥就HBM4003訂獨家授權 有資格獲價值逾1.05億美元前期對價
2026-02-23T  
《盈喜》和鉑醫藥料去年溢利按年增長最多34.2倍
2026-02-04T  
和鉑醫藥-B擬動用最多3億元回購公司股份
2026-01-29T  
和鉑醫藥行使認股權證 於Spruce Biosciences持股逾3%
2026-01-19T  
和鉑醫藥-B授出30.9萬份購股權
2026-01-02T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.